Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1105

1.

Association of Hyponatremia With Survival in Patients With Castration-resistant Prostate Cancer: A Clinical Commentary.

Stangl-Kremser J, Kramer G, Shariat SF.

Clin Genitourin Cancer. 2019 Aug 20. pii: S1558-7673(19)30250-2. doi: 10.1016/j.clgc.2019.08.001. [Epub ahead of print]

PMID:
31623929
2.

Response assessment using [68 Ga]Ga-PSMA ligand PET in patients undergoing systemic therapy for metastatic castration-resistant prostate cancer.

Grubmüller B, Rasul S, Baltzer P, Fajkovic H, D'Andrea D, Berndl F, Maj-Hes A, Grubmüller KH, Mitterhauser M, Wadsak W, Pfaff S, Shariat SF, Hacker M, Kramer G, Hartenbach M.

Prostate. 2019 Oct 15. doi: 10.1002/pros.23919. [Epub ahead of print]

PMID:
31614001
3.

What Is the Prognostic and Clinical Importance of Urothelial and Nonurothelial Histological Variants of Bladder Cancer in Predicting Oncological Outcomes in Patients with Muscle-invasive and Metastatic Bladder Cancer? A European Association of Urology Muscle Invasive and Metastatic Bladder Cancer Guidelines Panel Systematic Review.

Veskimäe E, Espinos EL, Bruins HM, Yuan Y, Sylvester R, Kamat AM, Shariat SF, Witjes JA, Compérat EM.

Eur Urol Oncol. 2019 Oct 7. pii: S2588-9311(19)30144-0. doi: 10.1016/j.euo.2019.09.003. [Epub ahead of print] Review.

PMID:
31601522
4.

Comprehensive analysis of in-hospital delirium after major surgical oncology procedures.

Bandini M, Marchioni M, Preisser F, Nazzani S, Tian Z, Graefen M, Montorsi F, Saad F, Shariat SF, Schips L, Briganti A, Karakiewicz PI.

Can Urol Assoc J. 2019 Sep 27. doi: 10.5489/cuaj.6030. [Epub ahead of print]

PMID:
31599720
5.

Diagnostic Value of 18F-fluorodeoxyglucose Positron Emission Tomography with Computed Tomography for Lymph Node Staging in Patients with Upper Tract Urothelial Carcinoma.

Voskuilen CS, Schweitzer D, Jensen JB, Nielsen AM, Joniau S, Muilwijk T, Necchi A, Azizi M, Spiess PE, Briganti A, Bandini M, Goffin K, Bouchelouche K, van Werkhoven E, Shariat SF, Xylinas E, Azawi NH, Ku JH, Foerster B, van Rhijn BWG, Vegt E, Hendricksen K.

Eur Urol Oncol. 2019 Oct 4. pii: S2588-9311(19)30145-2. doi: 10.1016/j.euo.2019.09.004. [Epub ahead of print]

PMID:
31591037
6.

TEMPORARY REMOVAL: Quality Indicators for Bladder Cancer Services: A Collaborative Review.

Leow JJ, Catto JWF, Efstathiou JA, Gore JL, Hussein AA, Shariat SF, Smith AB, Weizer AZ, Wirth M, Witjes JA, Trinh QD.

Eur Urol. 2019 Sep 26. pii: S0302-2838(19)30690-6. doi: 10.1016/j.eururo.2019.09.001. [Epub ahead of print]

PMID:
31563501
7.

The effect of radical cystectomy on survival in patients with metastatic urothelial carcinoma of the urinary bladder.

Luzzago S, Palumbo C, Rosiello G, Pecoraro A, Deuker M, Tian Z, Shariat SF, Saad F, de Cobelli O, Karakiewicz PI.

J Surg Oncol. 2019 Sep 28. doi: 10.1002/jso.25717. [Epub ahead of print]

PMID:
31562831
8.

Prognostic Value of Lactate Dehydrogenase in Metastatic Prostate Cancer: A Systematic Review and Meta-analysis.

Mori K, Kimura S, Parizi MK, Enikeev DV, Glybochko PV, Seebacher V, Fajkovic H, Mostafaei H, Lysenko I, Janisch F, Egawa S, Shariat SF.

Clin Genitourin Cancer. 2019 Jul 19. pii: S1558-7673(19)30225-3. doi: 10.1016/j.clgc.2019.07.009. [Epub ahead of print] Review.

PMID:
31558410
9.

Re: Enzalutamide with Standard First-line Therapy in Metastatic Prostate Cancer.

Huebner NA, Shariat SF.

Eur Urol. 2019 Sep 19. pii: S0302-2838(19)30679-7. doi: 10.1016/j.eururo.2019.08.029. [Epub ahead of print] No abstract available.

PMID:
31542306
10.

Do Younger Patients with Muscle-Invasive Bladder Cancer have Better Outcomes?

Janisch F, Yu H, Vetterlein MW, Dahlem R, Engel O, Fisch M, Shariat SF, Soave A, Rink M.

J Clin Med. 2019 Sep 13;8(9). pii: E1459. doi: 10.3390/jcm8091459.

11.

What Is the Significance of Variant Histology in Urothelial Carcinoma?

Lobo N, Shariat SF, Guo CC, Fernandez MI, Kassouf W, Choudhury A, Gao J, Williams SB, Galsky MD, Taylor JA 3rd, Roupret M, Kamat AM.

Eur Urol Focus. 2019 Sep 15. pii: S2405-4569(19)30278-0. doi: 10.1016/j.euf.2019.09.003. [Epub ahead of print] Review.

PMID:
31530497
12.

Predictive factors of the absence of residual disease at repeated transurethral resection of the bladder. Is there a possibility to avoid it in well-selected patients?

Soria F, D'Andrea D, Moschini M, Giordano A, Mazzoli S, Pizzuto G, Hurle R, Colombo R, Briganti A, Altieri V, Shariat SF, Gontero P.

Urol Oncol. 2019 Sep 14. pii: S1078-1439(19)30328-X. doi: 10.1016/j.urolonc.2019.08.010. [Epub ahead of print]

PMID:
31526650
13.

Contemporary Assessment of Long-Term Survival Rates in Patients With Stage I Nonseminoma Germ-Cell Tumor of the Testis: Population-Based Comparison Between Surveillance and Active Treatment After Initial Orchiectomy.

Mazzone E, Mistretta FA, Knipper S, Tian Z, Palumbo C, Gandaglia G, Soulieres D, Tilki D, Montorsi F, Shariat SF, Saad F, Briganti A, Karakiewicz PI.

Clin Genitourin Cancer. 2019 Aug 21. pii: S1558-7673(19)30258-7. doi: 10.1016/j.clgc.2019.08.009. [Epub ahead of print]

PMID:
31515197
14.

Do Not Learn a Technique, Learn the Biology Underlying the Disease: Techniques Evolve, Biology Prevails.

Moschini M, Shariat SF, Black P, Kamat AM, Stabile A, Cathelineau X, Kassouf W, Bochner BH, Xylinas E, Roupret M, Boorjian SA, Catto JW, Sanchez-Salas R.

Eur Urol. 2019 Sep 7. pii: S0302-2838(19)30670-0. doi: 10.1016/j.eururo.2019.08.021. [Epub ahead of print]

PMID:
31506227
15.

Prognostic value of T1 substaging on oncological outcomes in patients with non-muscle-invasive bladder urothelial carcinoma: a systematic literature review and meta-analysis.

Kardoust Parizi M, Enikeev D, Glybochko PV, Seebacher V, Janisch F, Fajkovic H, Chłosta PL, Shariat SF.

World J Urol. 2019 Sep 6. doi: 10.1007/s00345-019-02936-y. [Epub ahead of print]

PMID:
31493109
16.

Assessment of local tumor ablation and non-interventional management versus partial nephrectomy in T1a renal cell carcinoma.

Palumbo C, Mistretta FA, Knipper S, Mazzone E, Pecoraro A, Tian Z, Perrotte P, Antonelli A, Montorsi F, Shariat SF, Saad F, Simeone C, Briganti A, Lavallee LT, Karakiewicz PI.

Minerva Urol Nefrol. 2019 Sep 4. doi: 10.23736/S0393-2249.19.03496-9. [Epub ahead of print]

PMID:
31487976
17.

Prognostic Value of Variant Histology in Upper Tract Urothelial Carcinoma Treated with Nephroureterectomy: A Systematic Review and Meta-Analysis.

Mori K, Janisch F, Parizi MK, Mostafaei H, Lysenko I, Kimura S, Enikeev DV, Egawa S, Shariat SF.

J Urol. 2019 Sep 3:101097JU0000000000000523. doi: 10.1097/JU.0000000000000523. [Epub ahead of print]

PMID:
31479406
18.

Unmarried status is a barrier for access to treatment in patients with metastatic renal cell carcinoma.

Rosiello G, Knipper S, Palumbo C, Dzyuba-Negrean C, Pecoraro A, Mazzone E, Mistretta FA, Tian Z, Capitanio U, Montorsi F, Shariat SF, Saad F, Briganti A, Karakiewicz PI.

Int Urol Nephrol. 2019 Aug 29. doi: 10.1007/s11255-019-02266-3. [Epub ahead of print]

PMID:
31468289
19.

Contemporary North-American population-based validation of the International Germ Cell Consensus Classification for metastatic germ cell tumors of the testis.

Mazzone E, Knipper S, Mistretta FA, Tian Z, Palumbo C, Soulieres D, De Cobelli O, Montorsi F, Shariat SF, Saad F, Briganti A, Karakiewicz PI.

World J Urol. 2019 Aug 28. doi: 10.1007/s00345-019-02927-z. [Epub ahead of print]

PMID:
31463562
20.

European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update.

Babjuk M, Burger M, Compérat EM, Gontero P, Mostafid AH, Palou J, van Rhijn BWG, Rouprêt M, Shariat SF, Sylvester R, Zigeuner R, Capoun O, Cohen D, Escrig JLD, Hernández V, Peyronnet B, Seisen T, Soukup V.

Eur Urol. 2019 Nov;76(5):639-657. doi: 10.1016/j.eururo.2019.08.016. Epub 2019 Aug 20. Review.

PMID:
31443960

Supplemental Content

Loading ...
Support Center